Literature DB >> 11369527

Radiofrequency thermal ablation of hepatocellular carcinoma.

T Livraghi1, S Lazzaroni, F Meloni.   

Abstract

Radiofrequency (RF) ablation resulted in a higher complete necrosis than percutaneous ethanol injection (PEI), above all in infiltrating lesions, and requires fewer treatment sessions in the treatment of small size tumors. We achieved 90% of complete necrosis in hepatocellular carcinoma (HCC)<3 cm, 71% in medium (3-5 cm) and 45% in large (5.1-9 cm) HCC. However, near complete necrosis was obtained in the majority of the remaining tumors. PEI is preferable in lesions at risk with RF, i.e. adjacent to main biliary ducts or to intestinal loops. Our current 3-yr survival in child A patient with single HCC<5 cm is 85%.

Entities:  

Mesh:

Year:  2001        PMID: 11369527     DOI: 10.1016/s0929-8266(01)00128-8

Source DB:  PubMed          Journal:  Eur J Ultrasound        ISSN: 0929-8266


  24 in total

Review 1.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

2.  Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.

Authors:  Ming-De Lu; Hui-Xiong Xu; Xiao-Yan Xie; Xiao-Yu Yin; Jun-Wei Chen; Ming Kuang; Zuo-Feng Xu; Guang-Jian Liu; Yan-Lin Zheng
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 7.527

3.  Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes.

Authors:  Tan To Cheung; Kelvin K Ng; Kenneth S Chok; See Ching Chan; Ronnie T Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

4.  Case-control study of the RFA therapeutic effect of newly developed 4D US and conventional 2D US.

Authors:  Atsunori Kusakabe; Shunsuke Nojiri; Etsuko Iio; Kentaro Matsuura; Noboru Shinkai; Tomokatsu Miyaki; Takashi Joh
Journal:  J Med Ultrason (2001)       Date:  2012-07-31       Impact factor: 1.314

5.  Effect of radiofrequency ablation of the liver on cell-mediated immunity in rats.

Authors:  Hee Chul Yu; Jang Il Moon; Zhe-Wu Jin; Dae Yung Lee; Chan Young Kim; Chang Ho Song; Baik Hwan Cho
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

6.  Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma.

Authors:  Koichi Obara; Nobuyuki Matsumoto; Masaru Okamoto; Minoru Kobayashi; Hiroki Ikeda; Hideaki Takahashi; Yoshiki Katakura; Kotaro Matsunaga; Toshiya Ishii; Chiaki Okuse; Michihiro Suzuki; Fumio Itoh
Journal:  Hepatol Int       Date:  2008-01-29       Impact factor: 6.047

7.  Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma.

Authors:  Yao-Jun Zhang; Min-Shan Chen
Journal:  World J Hepatol       Date:  2010-04-27

8.  Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma.

Authors:  Li-Wu Lin; Xue-Ying Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue; Xiao-Dong Lin; Li-Yun Yu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  The imprint of radiofrequency in the management of hepatocellular carcinoma.

Authors:  Spiros Delis; Ioannis Bramis; Charikleia Triantopoulou; Juan Madariaga; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-up.

Authors:  Matthieu Lepetit-Coiffé; Hervé Laumonier; Olivier Seror; Bruno Quesson; Musa-Bahazid Sesay; Chrit T W Moonen; Nicolas Grenier; Hervé Trillaud
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.